PROSTACOX : Metastatic Prostate Chemotherapy

University Hospital, Rouen

Status: Completed

Conditions: Metastatic Prostate Cancer

Treatments: Drug: docetaxel and celecoxib

Study type: Observational

Funder types: Other

Identifiers

NCT00213694

2003/052/HP

Details and patient eligibility

About

Clinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation. Association of Docetaxel (J 15) and Celecoxib.

Full description

Association Docetaxel (J 15) and celecoxib Patient survival Biological parameter : PSA Clinical status RECIST evaluation

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion criteria

• metastatic prostate cancer
• ASCO progression criteria

Exclusion criteria

• other prostate chemotherapy